Prof Angeliki Malliri
Overview
Tumour initiation and progression result from inappropriate activation of intracellular signalling cascades. Rho-like GTPases are molecular switches in signalling pathways that regulate cytoskeletal and junctional organisation, as well as gene transcription. In this way, Rho proteins influence cell morphology, adhesion, motility, as well as cell cycle progression and cell survival. Rho proteins are transforming in vitro and are essential for Ras-mediated in vitro transformation. Moreover, data has emerged to directly implicate Rho proteins in tumour initiation and progression in vivo. Our group investigates how the activities of certain regulators of the Rho protein Rac are controlled. We are also identifying signalling events downstream of Rac that modulate tumour susceptibility and disease progression.
External positions
Member of the Molecular and Cellular Medicine Board, Medical Research Council (MRC)
Jun 2017 → May 2019
Scientific Advisory Committee, Worldwide Cancer Research
1 Oct 2012 → 31 Oct 2017
Editorial Board, Small GTPases - Taylor & Francis Online
Biology, Medicine and Health (BMH) Domains
Education / academic qualifications
- Doctor of Philosophy National Hellenic Research Foundation (1990 - 1994)
- Bachelor of Science Panepistimio Patron - University of Patras (1985 - 1989)
Related information
Publications
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review